Global Pharmaceutical REMS Market Size is valued at US$ 1.8 Bn in 2024 and is predicted to reach US$ 5.6 Bn by the year 2034 at an 12.3% CAGR during the forecast period for 2025-2034. A drug safety program called Pharmaceutical REMS (Risk Evaluation and Mitigation Strategies) is required by the U.S. Food and Drug Administration (FDA) for some pharmaceuticals that have substantial hazards but also provide considerable benefits when used as direct...
Report ID: 3140 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Global Blood-Based Biomarker Market Size is valued at USD 7.9 Bn in 2024 and is predicted to reach USD 15.9 Bn by the year 2034 at a 7.4% CAGR during the forecast period for 2025-2034. A blood-based biomarker refers to a measurable and quantifiable characteristic in the blood that indicates a particular physiological or pathological process, or a response to a therapeutic intervention. Biomarkers are valuable tools in medicine and research as th...
Report ID: 2244 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Theranostics Market Size is valued at USD 2.48 Bn in 2024 and is predicted to reach USD 9.33 Bn by the year 2034 at a 14.4% CAGR during the forecast period for 2025-2034. Theranostics refers to the practice of using two radioactive medications simultaneously, one for diagnosis and another for therapy, to treat the original tumor and any metastasized tumors. The term theranostics combines the word therapeutics and diagnostics or testing. Drug d...
Report ID: 2344 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 179
Global Manual Patch Clamp Market Size is predicted to grow at a 4.5% CAGR during the forecast period for 2025-2034. Manual patch clamp is a versatile, high-resolution, low-throughput approach for measuring the currents generated by a single cell in response to stimulation. With the addition of innovative tactics and an increasing client preference, this market has been growing faster. Patch-clamp is a popular approach for researching ion c...
Report ID: 2196 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Global Non-Invasive Respiratory Therapy Market Size is valued at USD 2.45 Bn in 2024 and is predicted to reach USD 4.04 Bn by the year 2034 at a 5.2% CAGR during the forecast period for 2025-2034. Non-invasive respiratory therapy refers to treatments and approaches that are used to manage respiratory disorders without the need for intrusive procedures like intubation or surgery. These treatments often treat respiratory diseases, including asthma...
Report ID: 2198 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Global Care Communications Market Size is valued at USD 3.3 Bn in 2024 and is predicted to reach USD 10.6 Bn by the year 2034 at a 12.6% CAGR during the forecast period for 2025-2034. Care communication pertains to the exchange of information and interactions among healthcare professionals, patients, and their families, intending to ensure the delivery of safe, effective, and patient-centred healthcare. The swift expansion of telehealth and tele...
Report ID: 2224 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Global Heparinoid Market Size is valued at USD 1.2 Billion in 2024 and is predicted to reach USD 1.7 Billion by the year 2034 at a 3.6% CAGR during the forecast period for 2025-2034. Heparinoid is an anti-thrombotic medication that decreases swelling in the veins just under the skin and helps to prevent the formation of tiny blood clots. To alleviate bruising, heparinoid is prescribed. Superficial thrombophlebitis causes internal bruising (haema...
Report ID: 2293 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Global Myasthenia Gravis Treatment Market Size is valued at USD 1.60 Bn in 2024 and is predicted to reach USD 3.34 Bn by the year 2034 at a 7.8% CAGR during the forecast period for 2025-2034. Myasthenia gravis is an uncommon neuromuscular illness characterized by gradual weakness of the muscles of the face, neck, upper and lower body, and respiratory system. Producing antibodies against the acetylcholine receptor disrupts the regular flow ...
Report ID: 2148 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 179
Global Integrase Inhibitors Market Size is valued at USD 15.8 Bn in 2024 and is predicted to reach USD 27.9 Bn by the year 2034 at a 6.0% CAGR during the forecast period for 2025-2034. Integrase inhibitors are a type of antiretroviral medications that work by inhibiting the viral enzyme integrase, which is responsible for mixing the viral genome into the DNA of the host cell. This is the mechanism of action of integrase inhibitors. Retr...
Report ID: 2089 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Global Eleuthero Market Size is valued at USD 663.0 Mn in 2024 and is predicted to reach USD 880.3 Mn by the year 2034 at a 3.0% CAGR during the forecast period for 2025-2034. Eleuthero is a shrub of the rose family that bears the common name "Siberian ginseng." False ginseng, at best. It can be utilized as an adaptogen in some cases. The use of eleuthero as an adaptogen is common. Several compounds in eleuthero have been shown to impact cogniti...
Report ID: 2100 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 178
Pharmaceuticals